FP
ICPT

Foundry Partners’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Foundry Partners’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-4,811
Closed -$1.14M – 280
2014
Q3 		$1.14M Buy
+4,811
New +$1.23M 0.11% 172

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Foundry Partners's ICPT Position: Q4 2014 in Review

Foundry Partners sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2014, closing a stake of 4,811 shares — an estimated $1.14M sold.

Foundry Partners first reported a position in ICPT in Q3 2014 and held it in 1 quarter. The position peaked at $1.14M in Q3 2014. 169 funds tracked by Wall St. Rank hold ICPT as of Q4 2014.

  • Foundry Partners reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2014 after selling out during the quarter.
  • Foundry Partners sold 4,811 Intercept Pharmaceuticals, Inc. shares in Q4 2014, an estimated $1.14M.
  • Foundry Partners first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2014 and held it in 1 quarter.
  • Foundry Partners's Intercept Pharmaceuticals, Inc. position peaked at $1.14M in Q3 2014.
  • 169 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2014.

Based on Foundry Partners's 13F filing for Q4 2014, filed 7 Jan 2015.